NDC 72943-0001 Ing Ampoule

Glycerin, Allantoin

NDC Product Code 72943-0001

NDC 72943-0001-1

Package Description: 90 mL in 1 BOX

NDC Product Information

Ing Ampoule with NDC 72943-0001 is a a human over the counter drug product labeled by Daonmedicos Co.. The generic name of Ing Ampoule is glycerin, allantoin. The product's dosage form is liquid and is administered via topical form.

Labeler Name: Daonmedicos Co.

Dosage Form: Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Ing Ampoule Active Ingredient(s)

What is the Active Ingredient(s) List?
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.

  • GLYCERIN 3 g/100mL

Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • WATER (UNII: 059QF0KO0R)
  • ALLANTOIN (UNII: 344S277G0Z)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: Daonmedicos Co.
Labeler Code: 72943
FDA Application Number: part347 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Marketing Category: OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 03-24-2019 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2020 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA’s requests for correction to deficient or non-compliant submissions. Values = ‘Y’ or ‘N’.

* Please review the disclaimer below.

Ing Ampoule Product Label Images

Ing Ampoule Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index

Otc - Active Ingredient


Inactive Ingredient

Dipropylene Glycol, Pentylene Glycol, Saccharomyces/Artemisia Princeps Leaf Ferment Filtrate, Niacinamide, Sodium , Chondroitin Sulfate, Hexacarboxymethyl Dipeptide-12, rh-Oligopeptide-1(10ppm), Butylene Glycol, Water, Yeast Extract, Butylene Glycol, Water, Yeast Beta-Glucan, Butylene Glycol, Water, Morus Alba Leaf Extract, Water, ,

an Adipocyte Conditioned Media Extract, ytosphingosine, ramide NP, ospholipids, prylyl Glycol, opolone, ytosterols, ualane

1,2-Hexanediol, -Decapeptide-7 , -Octapeptide-4, -Oligopeptide-9, -Pentapeptide-19, galloyl Tetrapeptide-19 , ipeptide-48,

cotinoyl Tripeptide-1, lmitoyl Pentapeptide-4 , alicin, opanediol , ter, drolyzed Pea Protein , ytosterols, cithin , ea Europaea , live) Fruit Oil, sqalane, Butyrospermum Parkii (Shea) Butter, Ceramide NP, Butylene Glycol, Water, Centella Asiatica Extract ,

Polygonum Cuspidatum Root Extract, Scutellaria Baicalensis Root Extract, Camellia Sinensis Leaf Extract , Glycyrrhiza Glabra (Licorice) Root Extract , hamomilla Recutita (Matricaria) Flower Extract, Rosmarinus Officinalis (Rosemary) Leaf Extract,

Butylene Glycol, Water, Triticum Vulgare (Wheat) Seed Extract , Butylene Glycol, Water, Echinacea Angustifolia Extract,

Glycerin, Water, Swiftlet Nest Extract, Butylene Glycol, Water, Pueraria Lobata Root Extract, Dimethicone, Water, Glycerin,

Butylene Glycol, PEG-20 Glyceryl Isostearate, Pentylene Glycol, Tocopheryl Acetate, Dimethicone/Vinyl Dimethicone, Crosspolymer, Diglycerin, 1,2-Hexanediol, Butylene Glycol, Copper Tripeptide-1 , Polysorbate 80, Propanediol , Aloe Barbadensis Leaf Extract, Bioflavonoids, Brassica Oleracea Italica (Broccoli) Extract, Sodium Polystyrene Sulfonate,

Dipotassium Glycyrrhizate, Cetyl Ethylhexanoate, Dimethyl Sulfone, Allantoin, Adenosine, Fragrance, Nonapeptide-29 ,Hexapeptide-8 , Nonapeptide-29 Pentapeptide-4, Panthenol, Isopentyldiol , Polyglyceryl-4 Oleate , Sucrose Palmitate

Ceramide NP, Propanediol , Butylene Glycol

Otc - Purpose

■ to reduce effectively the intensity of skin defects■ skin looks lighter■ reawakened for 7 days

Otc - Keep Out Of Reach Of Children

Keep out of reach of the children

Indications & Usage

Spread evenly over the skin


■ if following abnormal symptoms occurs after use , stop use and consult with a skin specialistred specks, swelling, itching■ don’t use on the part where there is injury, eczema, or dermatitisKeep out of reach of children■ if swallowed, get medical help or contact a person control center immediately

Dosage & Administration

For external use only

* Please review the disclaimer below.

Previous Code
Next Code